MODD$1.83+1.67%
Modular Medical, Inc.
Sector: Surgical & Medical Instruments & ApparatusIndustry: Medical - DevicesCountry: USExchange: Nasdaq
Mkt Cap:$14.92M
Float & O/S:
Inst Own:
DilutionScan read 22 of Modular Medical, Inc.'s SEC filings and found 15 warrant series, 2 ATM programs, 3 shelf registrations, 1 S-1 registration and 5 completed offerings on file for MODD. The latest dilution event on file is a registration statement on Aug 18, 2026. Analysis updated Sep 9, 2026.
Signal8 Summary
MODD
Going-concern warning and reverse split
Snapshot
Modular Medical is a pre-revenue medical device company launching its first insulin pump. FY 2026 revenue was $0 with a net loss of $28.2M. Free cash flow was negative $27.7M, consuming the entire $6.9M cash balance in weeks at current burn rates.
What's Happening Right Now
- : The company announced plans to launch its Pivot insulin delivery system across five U.S. markets including Atlanta and Dallas beginning in October 2026.
- : The company formed a Pivot Innovation Council chaired by Dr. Robert Gabbay to guide clinical and commercial strategy.
- : Modular Medical partnered with IMO Health on a pilot to identify insulin pump patients directly within electronic health records.
- : The company's 10-K raised substantial doubt about its ability to continue as a going concern and disclosed a 1-for-30 reverse split effective March 31, 2026.
- : Modular Medical delivered insulin to the first patients using its Pivot tubeless patch pump, marking its transition from development to commercial operations.
